Sadelain M - Search Results

1

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.

Park JH, Nath K, Devlin SM, Sauter CS, Palomba ML, Shah G, Dahi P, Lin RJ, Scordo M, Perales MA, Shouval R, Tomas AA, Cathcart E, Mead E, Santomasso B, Holodny A, Brentjens RJ, Riviere I, Sadelain M. Park JH, et al. Among authors: sadelain m. Nat Med. 2023 Jul;29(7):1710-1717. doi: 10.1038/s41591-023-02404-6. Epub 2023 Jul 3. Nat Med. 2023. PMID: 37400640 Free PMC article. Clinical Trial.

2

Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection.

Hagani AB, Rivière I, Tan C, Krause A, Sadelain M. Hagani AB, et al. Among authors: sadelain m. J Gene Med. 1999 Sep-Oct;1(5):341-51. doi: 10.1002/(SICI)1521-2254(199909/10)1:5<341::AID-JGM58>3.0.CO;2-J. J Gene Med. 1999. PMID: 10738551

3

Retroviral-mediated gene transfer in primary murine and human T-lymphocytes.

Rivière I, Gallardo HF, Hagani AB, Sadelain M. Rivière I, et al. Among authors: sadelain m. Mol Biotechnol. 2000 Jun;15(2):133-42. doi: 10.1385/MB:15:2:133. Mol Biotechnol. 2000. PMID: 10949826

4

Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells.

Sadelain M, Frassoni F, Rivière I. Sadelain M, et al. Curr Opin Hematol. 2000 Nov;7(6):364-77. doi: 10.1097/00062752-200011000-00008. Curr Opin Hematol. 2000. PMID: 11055510 Review.

5

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.

Maher J, Brentjens RJ, Gunset G, Rivière I, Sadelain M. Maher J, et al. Among authors: sadelain m. Nat Biotechnol. 2002 Jan;20(1):70-5. doi: 10.1038/nbt0102-70. Nat Biotechnol. 2002. PMID: 11753365

6

Sturm und drang over suicidal lymphocytes.

Sadelain M, Rivière I. Sadelain M, et al. Mol Ther. 2002 Jun;5(6):655-7. doi: 10.1006/mthe.2002.0619. Mol Ther. 2002. PMID: 12027547 Free article. Review. No abstract available.

7

A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.

Rivella S, May C, Chadburn A, Rivière I, Sadelain M. Rivella S, et al. Among authors: sadelain m. Blood. 2003 Apr 15;101(8):2932-9. doi: 10.1182/blood-2002-10-3305. Epub 2002 Dec 12. Blood. 2003. PMID: 12480689 Free article.

8

Targeting tumours with genetically enhanced T lymphocytes.

Sadelain M, Rivière I, Brentjens R. Sadelain M, et al. Nat Rev Cancer. 2003 Jan;3(1):35-45. doi: 10.1038/nrc971. Nat Rev Cancer. 2003. PMID: 12509765 Review.

9

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

Brentjens RJ, Latouche JB, Santos E, Marti F, Gong MC, Lyddane C, King PD, Larson S, Weiss M, Rivière I, Sadelain M. Brentjens RJ, et al. Among authors: sadelain m. Nat Med. 2003 Mar;9(3):279-86. doi: 10.1038/nm827. Epub 2003 Feb 10. Nat Med. 2003. PMID: 12579196

10

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.

Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, Riviere I, Sadelain M, O'Reilly RJ, Larson SM, Tjuvajev JG. Koehne G, et al. Among authors: sadelain m. Nat Biotechnol. 2003 Apr;21(4):405-13. doi: 10.1038/nbt805. Epub 2003 Mar 24. Nat Biotechnol. 2003. PMID: 12652311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters